GHP Noetic Science-Psychedelic Pharma (TSXV:PSYF.P) EV-to-EBIT : 7.08 (As of Jun. 15, 2024)

GHP Noetic Science-Psychedelic Pharma EV-to-EBIT Chart

GHP Noetic Science-Psychedelic Pharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
EV-to-EBIT	Get a 7-Day Free Trial									-14.36	-9.24	6.60	7.49	6.70

Competitive Comparison of GHP Noetic Science-Psychedelic Pharma's EV-to-EBIT

For the Shell Companies subindustry, GHP Noetic Science-Psychedelic Pharma's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GHP Noetic Science-Psychedelic Pharma's EV-to-EBIT Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, GHP Noetic Science-Psychedelic Pharma's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where GHP Noetic Science-Psychedelic Pharma's EV-to-EBIT falls into.

GHP Noetic Science-Psychedelic Pharma EV-to-EBIT Calculation

GHP Noetic Science-Psychedelic Pharma's EV-to-EBIT for today is calculated as:

GHP Noetic Science-Psychedelic Pharma's current Enterprise Value is C$-0.56 Mil.
GHP Noetic Science-Psychedelic Pharma's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GHP Noetic Science-Psychedelic Pharma  (TSXV:PSYF.P) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

GHP Noetic Science-Psychedelic Pharma's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

GHP Noetic Science-Psychedelic Pharma's Enterprise Value for the quarter that ended in Jun. 2023 was C$-0.53 Mil.
GHP Noetic Science-Psychedelic Pharma's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GHP Noetic Science-Psychedelic Pharma EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of GHP Noetic Science-Psychedelic Pharma's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

GHP Noetic Science-Psychedelic Pharma (TSXV:PSYF.P) Business Description